Treatment of psoriasis includes topical therapy, systemic therapy and phototherapy. It is not a contraindication to treat patients with pre-existing psoriasis with interferon-alpha. Plaque psoriasis is the most common presentation of the disease. This exacerbated inflammation results in the progressive creation of resident memory self-reactive cells that in-turn contribute to recruiting inflammatory mediators that result in a life-long recurrent chronic inflammatory skin disease.
Nanoemulsion As A Topical Delivery System Of Antipsoriatic Drugs